Introduction to Special Issue on ‘Statistical Methods for HIV/AIDS Research’

[1] Fauci AS(2020)Four decades of HIV/AIDS - much accomplished, much to do N Engl J Med 383 1-4

[2] Lane HC(2019)A method for estimating the proportion of HIV infected persons that have been diagnosed and application to China Stat Biosci undefined undefined-undefined

[3] Brookmeyer R(2020)Comparison of HIV prevalence among antenatal clinic attendees estimated from routine testing and unlinked anonymous Stat Biosci undefined undefined-undefined

[4] Wu Z(2019)Measuring surrogacy in clinical research with an application to studying surrogate markers for HIV treatment-as-prevention Stat Biosci undefined undefined-undefined

[5] Sheng B(2019)Generating survival times using Cox proportional hazards models with cyclic and piecewise time-varying covariates Stat Biosci undefined undefined-undefined

[6] Eaton JW(2020)Methods for feature selection in down-selection of vaccine regimens based on multivariate immune response endpoints Stat Biosci undefined undefined-undefined

[7] Mahy M(2020)Variable selection in threshold regression model with applications to HIV drug adherence data Stat Biosci undefined undefined-undefined

[8] Bao L(2019)Deductive semiparametric estimation in double-sampling designs with application to PEPFAR Stat Biosci undefined undefined-undefined

[9] Zhuang R(2020)Design and analysis considerations for a sequentially randomized HIV prevention trial Stat Biosci undefined undefined-undefined

[10] Chen YQ(2020)Designing HIV vaccine efficacy trials in the context of highly effective non-vaccine prevention modalities Stat Biosci undefined undefined-undefined

[1] Fauci AS(2020)Four decades of HIV/AIDS - much accomplished, much to do N Engl J Med 383 1-4

[2] Lane HC(2019)A method for estimating the proportion of HIV infected persons that have been diagnosed and application to China Stat Biosci undefined undefined-undefined

[3] Brookmeyer R(2020)Comparison of HIV prevalence among antenatal clinic attendees estimated from routine testing and unlinked anonymous Stat Biosci undefined undefined-undefined

[4] Wu Z(2019)Measuring surrogacy in clinical research with an application to studying surrogate markers for HIV treatment-as-prevention Stat Biosci undefined undefined-undefined

[5] Sheng B(2019)Generating survival times using Cox proportional hazards models with cyclic and piecewise time-varying covariates Stat Biosci undefined undefined-undefined

[6] Eaton JW(2020)Methods for feature selection in down-selection of vaccine regimens based on multivariate immune response endpoints Stat Biosci undefined undefined-undefined

[7] Mahy M(2020)Variable selection in threshold regression model with applications to HIV drug adherence data Stat Biosci undefined undefined-undefined

[8] Bao L(2019)Deductive semiparametric estimation in double-sampling designs with application to PEPFAR Stat Biosci undefined undefined-undefined

[9] Zhuang R(2020)Design and analysis considerations for a sequentially randomized HIV prevention trial Stat Biosci undefined undefined-undefined

[10] Chen YQ(2020)Designing HIV vaccine efficacy trials in the context of highly effective non-vaccine prevention modalities Stat Biosci undefined undefined-undefined